NET PROFIT (x1000 EUR)
EMPLOYEES
Biostata ApS
Closing information (x1000 EUR)
| Closing information | 2025/09 | 2024/09 | 2023/09 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-32
|
58
|
-193 |
| Total assets |
727
|
725
|
774 |
| Current assets |
689
|
688
|
730 |
| Current liabilities |
382
|
359
|
457 |
| Equity capital |
221
|
246
|
201 |
| - share capital |
27
|
27
|
27 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2025/09 | 2024/09 | 2023/09 |
| Solvency |
30.4%
|
33.9%
|
26.0% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
180.4%
|
191.6%
|
159.7% |
| Return on equity (ROE) |
-14.5%
|
23.6%
|
-96.0% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/09 | 2024/09 | 2023/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.